• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Treatment-Resistant Depression

  • ID: 2222123
  • March 2013
  • 228 Pages
  • John Wiley and Sons Ltd

The first book devoted to a challenging disorder that affects millions of people around the world.  Essential reading for all psychiatrists who manage these patients.

Note: Product cover images may vary from those shown

List of Contributors vii

Foreword ix

1 Definitions and Predictors of Treatment-resistant Depression 1
Daniel Souery and William Pitchot

2 Treatment-resistant Depression: A Separate Disorder – A New Approach 21
Hans-Jürgen Möller, Florian Seemüller, Rebecca Schennach and Ramesh K. Gupta

3 Genetics of Treatment-resistant Depression 43
Chiara Fabbri, Stefano Porcelli and Alessandro Serretti

4 Is There a Role for Switching Antidepressants in Treatment-resistant Depression? 91
Stuart Montgomery

5 The Role of Atypical Antipsychotics in Inadequateresponse and Treatment-resistant Depression 107
Siegfried Kasper and Elena Akimova

6 Lithium, Thyroid Hormones and Further Augmentation Strategies in Treatment-resistant Depression 129
Robert Haußmann and Michael Bauer

7 The Role of Nonpharmacological Interventions in Treatment-resistant Depression 159
Thomas E. Schläpfer and Sarah Kayser

8 The Role of Psychotherapy in the Management of Treatment-resistant Depression 183
Michael E. Thase

Index 209

Note: Product cover images may vary from those shown

“After all, this book is recommended for the young psychiatrist, who wants to read an easy introduction to the fascinating world of treatment of resistant depression.”  (Acta Psychiatrica Scandinavica, 9 November 2013)

“This is a monograph, which could be of great interest to psychiatrists managing patients with TRD. The chapters are written clearly, and the references are comprehensive and up-to-date.”  (Human Psychopharmacology: Clinical & Experimental, 6 November 2013)

“The editors should be congratulated for accomplishing the amazing feat of presenting so much information in such a compact book. With an investment of just a few hours, readers can be updated on a very complicated subject . . . The editors should be commended on detailing a variety of treatment options, including nonpharmacological options, which other books fail to emphasize.”  (Doody’s, 23 August 2013)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

AB Sciex Eli Lilly and Company B. Braun Melsungen AG Astellas Pharma, Inc. Hologic Corporation Merck & Co., Inc.